ARTICLE | Company News
Phylos progress in Amgen deal
August 24, 2000 7:00 AM UTC
Under its drug discovery collaboration with AMGN, Phylos said it used its PROfusion peptide and protein selection technology to identify high-affinity binding agents to certain AMGN therapeutic target...